Skip to main content

Tech-oriented NYC students visit Cornell

A busload of New York City high school students hit pause on city life to visit Cornell’s Ithaca campus, as part of a summer program that’s equipping the next generation of technical entrepreneurs.

In fashion, origami turns function into form

A skirt to be showcased at Vancouver Fashion Week was directly inspired by Cornell physics research on using origami to tailor the mechanical properties of materials.

LGBT perspectives on academia could foster inclusivity

A Weill Cornell Medical College research team surveyed nearly 350 LGBT doctors, nurses and other health care professionals and trainees to better understand the support they receive and the obstacles they face in academia.

Awards nurture Cornell, N.Y. industry partnerships

Center for Advanced Technology awards support Cornell life science faculty and research associates to develop biotechnologies with commercial potential.

End-of-life cancer chemotherapy: more harm than good

A new Weill Cornell Medical College study finds treating terminal late-stage cancer patients with chemotherapy does not improve quality of life and are of no benefit to overall survival.

AAP program for executives focuses on New York City

Twenty-two architecture and urban design professionals from China took part in the College of Architecture, Art and Planning’s first international executive education program.

Immune cells in lung cancer offer new drug targets

Lung cancers attract circulating immune cells to the tumor mass, where the cancer reprograms them to support its growth and progression, researchers from Weill Cornell Medical College have found.

Bacterial endocarditis increases stroke risk for extended period

Patients who develop bacterial endocarditis have an elevated risk of stroke beginning four months before, and up to five months after diagnosis – a period significantly longer than previously reported.

Tumor-suppressing gene lends insight to cancer treatment

Weill Cornell Medical College researchers have found that if PTEN, a known tumor-suppressor gene, has mutated or is absent, the DNA replication process derails and can lead to cancer development.